METHODS OF TREATING SARS-COV-2 INFECTION USING INHIBITORS OF LIPOGENESIS

摘要

The present disclosure provides methods of treating a SARS-CoV-2 infection in a patient infected with SARS-CoV-2. The present disclosure provides pharmaceutical compositions comprising an inhibitor of lipogenesis, optionally, in combination with an RdRp inhibitor and/or an anti-inflammatory agent.